Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functions.
Factor VII activating protease (FSAP) is associated with cardiovascular diseases and liver fibrosis. To understand the regulation of its proteolytic activity we have characterized recombinant FSAP-mutants over-expressed in HEK-293 cells. The secreted FSAP-protein concentration correlated inversely with the enzymatic activity of the FSAP-mutants. Over-expression of enzymatically active FSAP decreased cell viability, whereas inactive variants were expressed and secreted in adequate amounts. The naturally occurring G534E-variant exhibited reduced proteolytic activity. The DeltaEGF-3 mutant showed diminished binding to and activation by heparin. Hence, regulation of FSAP activity is dependent on its EGF-3 domain and over-expression of active variants induces cell death.
Muhl
Lars
L
Institute for Biochemistry, Medical School, Justus-Liebig-University Giessen, Giessen, Germany.
Hersemeyer
Karin
K
Preissner
Klaus T
KT
Weimer
Thomas
T
Kanse
Sandip M
SM
D020134:Catalytic Domain / Q000235:genetics; D002460:Cell Line; D015870:Gene Expression; D014644:Genetic Variation; D006493:Heparin / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007527:Isoenzymes / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D007700:Kinetics; D016297:Mutagenesis, Site-Directed; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D012697:Serine Endopeptidases / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*
D007527:Isoenzymes; D011994:Recombinant Proteins; D006493:Heparin; C433550:HABP2 protein, human; D012697:Serine Endopeptidases